Non-Hodgkin's lymphoma in children

Area of Science:

• Pediatric Oncology
• Hematology
• Pathology

Background:

• Non-Hodgkin's malignant lymphoma (NHL) in children presents diverse clinical and pathological features.
• Distinguishing NHL subtypes in children historically relied on cytological and histological methods.

Purpose of the Study:

• To describe the clinical and pathological features of pediatric non-Hodgkin's malignant lymphoma.
• To evaluate the relationship between non-Hodgkin's lymphoma and acute leukemias in children.
• To propose a unified classification and treatment approach for these conditions.

Main Methods:

• Retrospective analysis of clinical and pathological data from 64 children with non-Hodgkin's malignant lymphoma.
• Review of cytological and histological findings.
• Comparison of features with acute lymphocytic and histiocytic leukemias.

Main Results:

• Forty-one cases were diffuse, undifferentiated, non-Burkitt lymphoma (lymphoblastic lymphoma) with a median survival of 1 year.
• Nineteen cases were diffuse, poorly differentiated, histiocytic lymphoma with a median survival of 6 months.
• Lymphoblastic and histiocytic lymphomas showed similarities to acute lymphocytic and histiocytic leukemias, respectively.

Conclusions:

• Pediatric non-Hodgkin's lymphomas and acute leukemias may represent a spectrum of the same disease, challenging traditional separation by cytological/histological methods.
• A unified classification using newer methods is recommended for lymphocytic and histiocytic cancers.
• Treatment recommendations include local irradiation for Stage I and anti-leukemic therapies for Stages II-IV, with consideration for staging laparotomy.